Announcements Trials
Browse Landscape

Phase

Phase 2 25Phase NA 13Phase 1 6Phase 1/2 5Phase EARLY_PHASE1 1Phase 4 1Phase 2/3 1

Status

Completed 48Terminated 17Unknown 14Recruiting 12Active not recruiting 8Withdrawn 5Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5Gynecologic 1

Conditions

Breast Neoplasms 32Carcinoma, Non-Small-Cell Lung 29Leukemia, Myeloid, Acute 27Melanoma 25Neoplasms 22Lymphoma 21Pancreatic Neoplasms 18Multiple Myeloma 18Recurrence 17Lung Neoplasms 17Leukemia 17Ovarian Neoplasms 16Neoplasm Metastasis 15Lymphoma, Non-Hodgkin 15Carcinoma, Hepatocellular 15Colorectal Neoplasms 14Lymphoma, Follicular 13Myelodysplastic Syndromes 12Lymphoma, B-Cell 12Leukemia, Lymphocytic, Chronic, B-Cell 12Burkitt Lymphoma 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Lymphoma, Large B-Cell, Diffuse 11Prostatic Neoplasms 10Lymphoma, Mantle-Cell 10Brain Neoplasms 10Stomach Neoplasms 9Squamous Cell Carcinoma of Head and Neck 9Liver Neoplasms 9Glioma 9

Interventions

Oxaliplatin 2Fluorouracil 2Capecitabine 2infigratinib 1dehydroftorafur 1Radiotherapy 1Radiation 1Proton Therapy 1Leucovorin 1Irinotecan 1Hydralazine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1/2 × Withdrawn × Rectal Neoplasms × Clear all
NCT01097239 2020-11-20

Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer

Imperial College London

Phase 1/2 Withdrawn
GastrointestinalGynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Rectal Neoplasms, Vaginal Neoplasms, Endometrial Neoplasms

NCT01302613 2020-08-20

Altered Chemotherapy Sequencing During Neoadjuvant Therapy for Patients With Stage II or III Rectal Adenocarcinoma

University of Texas Southwestern Medical Center

Phase 1/2 Withdrawn
Gastrointestinal

Rectal Neoplasms

NCT02575508 2016-05-20

Pan FGFR Kinase Inhibitor BGJ398 and Combination Chemotherapy in Treating Patients With Untreated Metastatic Pancreatic Cancer

Roswell Park Cancer Institute

Phase 1/2 Withdrawn
Gastrointestinal

Colonic Neoplasms, Pancreatic Neoplasms, Rectal Neoplasms

NCT00575640 2015-03-04

Hydralazine as a Demethylating Agent in Rectal Cancer

University of Arkansas

Phase 1/2 Withdrawn
Gastrointestinal

Rectal Neoplasms

NCT00503932 2012-03-22

Proton Therapy With Capecitabine for Rectal Cancer

M.D. Anderson Cancer Center

Phase 1/2 Withdrawn
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡